Serial #79266494
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79266494 Trademark

Serial Number: 79266494 • Registration: 6121173

Serial #79266494 is a trademark filed by Yangtze River Pharmaceutical (Group) Co., Ltd. on August 5, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Yangtze River Pharmaceutical (Group) Co., Ltd. (9 trademarks)

No.1, South Yangtze River Road
Taizhou, Jiangsu 225300 , CN

Entity Type: 99

Trademark Details

Filing Date

August 5, 2019

Registration Date

August 11, 2020

Published for Opposition

May 26, 2020

Goods & Services

Medical preparations, namely, foot, hand and skin creams for diabetics; Medical preparation, namely, anti-cancer preparations; chemico-pharmaceutical preparations, namely, anti-infectives, pain relief medication, Chinese traditional medicinal herbs; radiological contrast substances for medical purposes; analgesics; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; medicines for human purposes, namely, anti-infectives, pain relief medication, cardiovascular pharmaceuticals, digestives for pharmaceutical purposes, Chinese traditional medicinal herbs, tumor suppressing agents, X-ray contrast agents, pharmaceutical preparations acting on the central nervous system; medicinal drinks; injectable pharmaceuticals for treatment of anaphylactic reactions; medicinal ointments for treating dermatological conditions; Chinese medicine nostrum namely, medicinal herbs; pills for pharmaceutical purposes namely anti-infectives, pain relief medication, cardiovascular pharmaceuticals, digestives for pharmaceutical purposes, Chinese traditional medicinal herbs, tumor suppressing agents, X-ray contrast agents, pharmaceutical preparations acting on the central nervous system; sticking plasters for medical purposes; biochemicial drug in the nature of biological preparations for the treatment of cancer; blood for medical purposes; gelatin capsules sold empty for pharmaceuticals; alcohol for medicinal purposes; medicated eye-wash; dietetic foods adapted for medical purposes; depuratives for the body; non medicated additives for animal feed for use as nutritional supplement; vermin destroying preparations; wadding for medical purposes; preparations to facilitate teething, namely, teething gels

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Nov 20, 2025 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 11, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 13, 2021 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Dec 4, 2020 XXSS
GENERIC MADRID TRANSACTION CREATED
Dec 3, 2020 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 11, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 11, 2020 R.PR
NOTIFICATION PROCESSED BY IB
May 29, 2020 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 26, 2020 NPUB
PUBLISHED FOR OPPOSITION
May 26, 2020 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 13, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 13, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 6, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 18, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 17, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 16, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 16, 2020 TROA
REFUSAL PROCESSED BY IB
Dec 20, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 3, 2019 RFCS
REFUSAL PROCESSED BY MPU
Dec 2, 2019 RFRR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Nov 21, 2019 CORR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 8, 2019 RFCR
NON-FINAL ACTION WRITTEN
Nov 7, 2019 CNRT
ASSIGNED TO EXAMINER
Nov 4, 2019 DOCK
CORRECTION TRANSACTION RECEIVED FROM IB
Oct 25, 2019 CRCV
APPLICATION FILING RECEIPT MAILED
Sep 14, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 10, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 3, 2019 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Aug 29, 2019 SDRC